Literature DB >> 17125744

Genetic dissection of the tail suspension test: a mouse model of stress vulnerability and antidepressant response.

Xiaoqing Liu1, Devin Stancliffe, Samuel Lee, Shelly Mathur, Howard K Gershenfeld.   

Abstract

BACKGROUND: The tail suspension test (TST) is a mouse screening test for antidepressants.
METHODS: An F2 intercross was derived from NMRI and 129S6 inbred strains (n = 747). Mice underwent standardized TST with 2 sessions: (1) baseline and (2) imipramine (30 mg/kg, intraperitoneally) TST.
RESULTS: A whole genome scan of this intercross mapped significant basal TST quantitative trait loci (QTL) on chromosomes (chr) 5 (peak 61 cM, Lod 5.7), 12 (peak 43 cM, Lod 5.2), and 18 (peak 51 cM, Lod 3.0). A suggestive QTL on chr 4 (peak 62 cM; Lod 3.1) overlapped regions containing previously mapped QTLs. For TST imipramine response, QTL were mapped on chr 1, 4, and 5. The chromosome 5 locus affected basal TST, antidepressant immobility response, and tail suspension-induced hyperthermia (TSIH) behaviors. An outbred NMRI F2 population provided further evidence for a chr 5 QTL. This chr 5 region harbors a cluster of gamma aminobutyric acid (GABA)-A receptor subunits and the human syntenic region includes chr 4p, 1p11, 12q24, and 22q11.24. A significant TSIH QTL (Tsih1) mapped on chr 4 near the Leptin receptor (Lepr).
CONCLUSIONS: These QTL provide potential regions of interest for human genetic studies in stress-diathesis models of psychiatric illness and antidepressant responsiveness.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17125744     DOI: 10.1016/j.biopsych.2006.08.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  8 in total

1.  The genetic basis of adrenal gland weight and structure in BXD recombinant inbred mice.

Authors:  Domenico L Di Curzio; Daniel Goldowitz
Journal:  Mamm Genome       Date:  2011-02-24       Impact factor: 2.957

Review 2.  Rodent models of treatment-resistant depression.

Authors:  Barbara J Caldarone; Venetia Zachariou; Sarah L King
Journal:  Eur J Pharmacol       Date:  2014-11-21       Impact factor: 4.432

3.  Quantitative trait locus analysis identifies Gabra3 as a regulator of behavioral despair in mice.

Authors:  Brooke H Miller; Laura E Schultz; Bradley C Long; Mathew T Pletcher
Journal:  Mamm Genome       Date:  2010-05-29       Impact factor: 2.957

4.  Usp46 is a quantitative trait gene regulating mouse immobile behavior in the tail suspension and forced swimming tests.

Authors:  Shigeru Tomida; Takayoshi Mamiya; Hirotake Sakamaki; Masami Miura; Toshihiko Aosaki; Masao Masuda; Minae Niwa; Tsutomu Kameyama; Junya Kobayashi; Yuka Iwaki; Saki Imai; Akira Ishikawa; Kuniya Abe; Takashi Yoshimura; Toshitaka Nabeshima; Shizufumi Ebihara
Journal:  Nat Genet       Date:  2009-05-24       Impact factor: 38.330

5.  Ubiquitin-specific peptidase 46 (Usp46) regulates mouse immobile behavior in the tail suspension test through the GABAergic system.

Authors:  Saki Imai; Takayoshi Mamiya; Akira Tsukada; Yasuyuki Sakai; Akihiro Mouri; Toshitaka Nabeshima; Shizufumi Ebihara
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

6.  Phenotypic characterization of a genetically diverse panel of mice for behavioral despair and anxiety.

Authors:  Brooke H Miller; Laura E Schultz; Anisha Gulati; Andrew I Su; Mathew T Pletcher
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

7.  Convergent evidence from mouse and human studies suggests the involvement of zinc finger protein 326 gene in antidepressant treatment response.

Authors:  Ying-Jay Liou; Chien-Hsiun Chen; Chih-Ya Cheng; Shiow-Yi Chen; Tai-Jui Chen; Younger W-Y Yu; Fang-Shin Nian; Shih-Jen Tsai; Chen-Jee Hong
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

8.  Quantitative traits for the tail suspension test: automation, optimization, and BXD RI mapping.

Authors:  Heena V Lad; Lin Liu; José L Payá-Cano; Cathy Fernandes; Leonard C Schalkwyk
Journal:  Mamm Genome       Date:  2007-07-07       Impact factor: 2.957

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.